Concepedia

Stuart Oliver

SO

23

Publications

1.4K

Citations

18

H-Index

1995

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Covance (United Kingdom)

AstraZeneca (United States)

AstraZeneca (Brazil)

Pfizer (United Kingdom)

Stuart Oliver is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1995–2019

23

Publications

23

Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects

Renli Teng, Stuart Oliver, Martin A. Hayes et al. · Drug Metabolism and Disposition · 2010 · 260 citations

Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety

Lynn Purkins, Nolan Wood, Katie Greenhalgh et al. · British Journal of Clinical Pharmacology · 2003 · 144 citations · Full text

Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers

John D. Iuliucci, Stuart Oliver, Steven K. Morley et al. · The Journal of Clinical Pharmacology · 2001 · 124 citations

The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent

Lynn Purkins, Nolan Wood, Katie Greenhalgh et al. · British Journal of Clinical Pharmacology · 2003 · 115 citations · Full text

Pharmacokinetics of Vandetanib: Three Phase I Studies in Healthy Subjects

Paul Martín, Stuart Oliver, Sarah-Jane Kennedy et al. · Clinical Therapeutics · 2011 · 84 citations

, , +5

Rows per page

1–5 of 23